Compounds for the treatment of psychiatric or substance abuse disorders
US7863254B2 · kind B2 · utility
0Cited by
39References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 1, 2003 |
| Grant date | Jan 4, 2011 |
| Priority date | — |
| Expiry date | May 1, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods for treating or preventing psychiatric and substance abuse disorders, involving administration of a therapeutically-effective amount of a cytosine-containing or cytidine-containing compound, creatine-containing compound, adenosine-containing, or adenosine-elevating compound to a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.